Orlando Health Ventures — Full Portfolio
4 tracked investments · listed companies and verified rows first
Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.
BiotechMedical Devices
Co-investorsRex Health VenturesSolas BioVentures
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.
Austin, US
John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)
Co-investorsRex Health Ventures
Sensydia develops non-invasive wireless cardiac monitoring technology using machine learning to diagnose and manage heart disease.
AI & Machine LearningHardwareHealthtechMedical DevicesLos Angeles, US
Anthony Arnold(CEO)inDr. Aman Mahajan(CMO)Rusty Page(President & COO)in
BoardG. Bradford Jones(Director)William Kaiser(Executive Officer)inVictoria K. Grace(Director)in
Co-investorsColle Capital PartnersFrontier Venture Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.